Löser R - Search Results

1

In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.

Wosikowski K, Biedermann E, Rattel B, Breiter N, Jank P, Löser R, Jansen G, Peters GJ. Wosikowski K, et al. Among authors: loser r. Clin Cancer Res. 2003 May;9(5):1917-26. Clin Cancer Res. 2003. PMID: 12738750

2

WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells.

Wosikowski K, Mattern K, Schemainda I, Hasmann M, Rattel B, Löser R. Wosikowski K, et al. Among authors: loser r. Cancer Res. 2002 Feb 15;62(4):1057-62. Cancer Res. 2002. PMID: 11861382

3

Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.

Riebeseel K, Biedermann E, Löser R, Breiter N, Hanselmann R, Mülhaupt R, Unger C, Kratz F. Riebeseel K, et al. Among authors: loser r. Bioconjug Chem. 2002 Jul-Aug;13(4):773-85. doi: 10.1021/bc010098m. Bioconjug Chem. 2002. PMID: 12121133

4

In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants.

Nüssler V, Pelka-Fleisc R, Gieseler F, Hasmann M, Löser R, Gullis E, Stötzer O, Zwierzina H, Wilmanns W. Nüssler V, et al. Among authors: loser r. Leuk Lymphoma. 1998 Nov;31(5-6):589-97. doi: 10.3109/10428199809057619. Leuk Lymphoma. 1998. PMID: 9922050

5

Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells.

Wosikowski K, Küng W, Hasmann M, Löser R, Eppenberger U. Wosikowski K, et al. Among authors: loser r. Int J Cancer. 1993 Jan 21;53(2):290-7. doi: 10.1002/ijc.2910530220. Int J Cancer. 1993. PMID: 8425767

6

Preclinical data for Droloxifene.

Hasmann M, Rattel B, Löser R. Hasmann M, et al. Among authors: loser r. Cancer Lett. 1994 Sep 15;84(2):101-16. doi: 10.1016/0304-3835(94)90364-6. Cancer Lett. 1994. PMID: 8076367 Review.

7

Effect of continuous vs intermittent application of 3-OH-tamoxifen or tamoxifen on the proliferation of the human breast cancer cell line MCF-7 M1.

Dietel M, Löser R, Röhlke P, Jonat W, Niendorf A, Gerding D, Kohr A, Hölzel F, Arps H. Dietel M, et al. Among authors: loser r. J Cancer Res Clin Oncol. 1989;115(1):36-40. doi: 10.1007/BF00391597. J Cancer Res Clin Oncol. 1989. PMID: 2921271

8

Pharmacological activities of droloxifene isomers.

Löser R, Seibel K, Huber HJ. Löser R, et al. Anticancer Res. 1988 Nov-Dec;8(6):1271-4. Anticancer Res. 1988. PMID: 3218958

9

In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen.

Löser R, Seibel K, Roos W, Eppenberger U. Löser R, et al. Eur J Cancer Clin Oncol. 1985 Aug;21(8):985-90. doi: 10.1016/0277-5379(85)90119-1. Eur J Cancer Clin Oncol. 1985. PMID: 4043181

10

Inhibition of cholesterol synthesis in vitro by extracts and isolated compounds prepared from garlic and wild garlic.

Sendl A, Schliack M, Löser R, Stanislaus F, Wagner H. Sendl A, et al. Among authors: loser r. Atherosclerosis. 1992 May;94(1):79-85. doi: 10.1016/0021-9150(92)90190-r. Atherosclerosis. 1992. PMID: 1632861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results